Needham 将 Synopsys 目标价从 580 上调至 620 美元、维持买入，但对 GPT-Synopsys 的 AI 战略优势存疑

Synopsys ( SNPS ) was in the spotlight on Monday as Needham upped its price target  on the electronic design automation firm after it recently held its investor day. “We liked virtually everything we heard, until the GPT-Synopsys announcement sent us scrambling to understand exactly what it is and, more importantly, what it means for SNPS and the EDA industry,” Needham analyst Charles Shi wrote in a note to clients. “We spent the following week speaking to EDA experts and end users, and concluded that GPT-Synopsys may not be a slam dunk as the initial market reaction would suggest. We think the AI EDA landscape is undergoing a shakeup, and the jury is still out on what will be the ultimate AI EDA leader. That being said, this remains one of the best Investor Days we have attended so far, with EDA/IP re-acceleration and SNPS' discount valuation still making SNPS a compelling case for investment.” Shi raised his price target on Synopsys to $620 from $580 and reiterated his Buy rating on the stock. Delving deeper, Shi said the release of GPT-Synopsys, which Synopsys worked on with OpenAI ( OPENAI ), contrasts with how electronic design automation firms approach artificial intelligence. “We believe that GPT-Synopsys means that SNPS is deviating away from a tacit alignment on AI among EDA companies,” Shi explained, adding that Synopsys, Cadence Design Systems ( CDNS ) and Siemens all had “similar” strategies when it comes to AI, putting AI wrappers on existing tools. “The jury is still out on what strategy will win AI EDA GPT-Synopsys is likely the top debate in AI EDA,” Shi posited. “It is part of a larger debate on the future of LLMs--are they commodities or monopolies? We see the clear benefits of having specially post-trained LLMs with EDA knowledge like GPT-Synopsys, but can also see that much of the advantages could get eroded as generic LLMs will likely gain EDA knowledge over time as more end users use EDA agents.”